Skip to main content
Top
Published in: BMC Medicine 1/2022

Open Access 01-12-2022 | Colorectal Cancer | Research article

External validation of models for predicting risk of colorectal cancer using the China Kadoorie Biobank

Authors: Roxanna E. Abhari, Blake Thomson, Ling Yang, Iona Millwood, Yu Guo, Xiaoming Yang, Jun Lv, Daniel Avery, Pei Pei, Peng Wen, Canqing Yu, Yiping Chen, Junshi Chen, Liming Li, Zhengming Chen, Christiana Kartsonaki

Published in: BMC Medicine | Issue 1/2022

Login to get access

Abstract

Background

In China, colorectal cancer (CRC) incidence and mortality have been steadily increasing over the last decades. Risk models to predict incident CRC have been developed in various populations, but they have not been systematically externally validated in a Chinese population. 
This study aimed to assess the performance of risk scores in predicting CRC using the China Kadoorie Biobank (CKB), one of the largest and geographically diverse prospective cohort studies in China.

Methods

Nine models were externally validated in 512,415 participants in CKB and included 2976 cases of CRC. Model discrimination was assessed, overall and by sex, age, site, and geographic location, using the area under the receiver operating characteristic curve (AUC). Model discrimination of these nine models was compared to a model using age alone. Calibration was assessed for five models, and they were re-calibrated in CKB.

Results

The three models with the highest discrimination (Ma (Cox model) AUC 0.70 [95% CI 0.69–0.71]; Aleksandrova 0.70 [0.69–0.71]; Hong 0.69 [0.67–0.71]) included the variables age, smoking, and alcohol. These models performed significantly better than using a model based on age alone (AUC of 0.65 [95% CI 0.64–0.66]). Model discrimination was generally higher in younger participants, males, urban environments, and for colon cancer. The two models (Guo and Chen) developed in Chinese populations did not perform better than the others. Among the 10% of participants with the highest risk, the three best performing models identified 24–26% of participants that went on to develop CRC.

Conclusions

Several risk models based on easily obtainable demographic and modifiable lifestyle factor have good discrimination in a Chinese population. The three best performing models have a higher discrimination than using a model based on age alone.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed
2.
go back to reference Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.PubMedCrossRef Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.PubMedCrossRef
3.
go back to reference Haghighat S, Sussman DA, Deshpande A. US Preventive services task force recommendation statement on screening for colorectal cancer. JAMA. 2021;326(13):1328.PubMedCrossRef Haghighat S, Sussman DA, Deshpande A. US Preventive services task force recommendation statement on screening for colorectal cancer. JAMA. 2021;326(13):1328.PubMedCrossRef
5.
go back to reference Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut. 2012;61(10):1439–46.PubMedCrossRef Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut. 2012;61(10):1439–46.PubMedCrossRef
7.
go back to reference Cao M, Li H, Sun D, He S, Yu Y, Li J, et al. Cancer screening in China: the current status, challenges, and suggestions. Cancer Lett. 2021;506:120–7.PubMedCrossRef Cao M, Li H, Sun D, He S, Yu Y, Li J, et al. Cancer screening in China: the current status, challenges, and suggestions. Cancer Lett. 2021;506:120–7.PubMedCrossRef
8.
go back to reference National Clinical Research Center for Digestive D, National Early Gastrointestinal-Cancer P, Treatment Center A, Chinese Society of Digestive E, Chinese Society of Health M, Digestive Endoscopy Professional Committee of Chinese Endoscopist A, et al. [Chinese consensus of early colorectal cancer screening (2019, Shanghai)]. Zhonghua Nei Ke Za Zhi. 2019;58(10):736–44. National Clinical Research Center for Digestive D, National Early Gastrointestinal-Cancer P, Treatment Center A, Chinese Society of Digestive E, Chinese Society of Health M, Digestive Endoscopy Professional Committee of Chinese Endoscopist A, et al. [Chinese consensus of early colorectal cancer screening (2019, Shanghai)]. Zhonghua Nei Ke Za Zhi. 2019;58(10):736–44.
9.
go back to reference Chen H, Li N, Ren J, Feng X, Lyu Z, Wei L, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019;68(8):1450–7.PubMedCrossRef Chen H, Li N, Ren J, Feng X, Lyu Z, Wei L, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019;68(8):1450–7.PubMedCrossRef
10.
go back to reference Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet. 2008;371(9616):923–31.PubMedPubMedCentralCrossRef Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet. 2008;371(9616):923–31.PubMedPubMedCentralCrossRef
11.
go back to reference Usher-Smith JA, Walter FM, Emery JD, Win AK, Griffin SJ. Risk prediction models for colorectal cancer: a systematic review. Cancer Prev Res (Phila). 2016;9(1):13–26.CrossRef Usher-Smith JA, Walter FM, Emery JD, Win AK, Griffin SJ. Risk prediction models for colorectal cancer: a systematic review. Cancer Prev Res (Phila). 2016;9(1):13–26.CrossRef
12.
go back to reference Ma E, Sasazuki S, Iwasaki M, Sawada N, Inoue M, Shoichiro T, et al. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34(5):534–41.PubMedCrossRef Ma E, Sasazuki S, Iwasaki M, Sawada N, Inoue M, Shoichiro T, et al. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34(5):534–41.PubMedCrossRef
13.
go back to reference Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD). Ann Intern Med. 2015;162(10):735–6.PubMedCrossRef Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD). Ann Intern Med. 2015;162(10):735–6.PubMedCrossRef
14.
go back to reference Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652–66.PubMedPubMedCentralCrossRef Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652–66.PubMedPubMedCentralCrossRef
15.
go back to reference Wang L, Jin G, Yu C, Lv J, Guo Y, Bian Z, et al. Cancer incidence in relation to body fatness among 0.5 million men and women: findings from the China Kadoorie Biobank. Int J Cancer. 2020;146(4):987–98.PubMedCrossRef Wang L, Jin G, Yu C, Lv J, Guo Y, Bian Z, et al. Cancer incidence in relation to body fatness among 0.5 million men and women: findings from the China Kadoorie Biobank. Int J Cancer. 2020;146(4):987–98.PubMedCrossRef
16.
go back to reference Im PK, Millwood IY, Chen Y, Guo Y, Du H, Kartsonaki C, et al. Problem drinking, wellbeing and mortality risk in Chinese men: findings from the China Kadoorie Biobank. Addiction. 2020;115(5):850–62.PubMedPubMedCentralCrossRef Im PK, Millwood IY, Chen Y, Guo Y, Du H, Kartsonaki C, et al. Problem drinking, wellbeing and mortality risk in Chinese men: findings from the China Kadoorie Biobank. Addiction. 2020;115(5):850–62.PubMedPubMedCentralCrossRef
17.
go back to reference Tian X, Du H, Li L, Bennett D, Gao R, Li S, et al. Fruit consumption and physical activity in relation to all-cause and cardiovascular mortality among 70,000 Chinese adults with pre-existing vascular disease. PLoS One. 2017;12(4):e0173054.PubMedPubMedCentralCrossRef Tian X, Du H, Li L, Bennett D, Gao R, Li S, et al. Fruit consumption and physical activity in relation to all-cause and cardiovascular mortality among 70,000 Chinese adults with pre-existing vascular disease. PLoS One. 2017;12(4):e0173054.PubMedPubMedCentralCrossRef
18.
go back to reference Millwood IY, Li L, Smith M, Guo Y, Yang L, Bian Z, et al. Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. Int J Epidemiol. 2013;42(3):816–27.PubMedPubMedCentralCrossRef Millwood IY, Li L, Smith M, Guo Y, Yang L, Bian Z, et al. Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. Int J Epidemiol. 2013;42(3):816–27.PubMedPubMedCentralCrossRef
19.
go back to reference Kalinowski A, Humphreys K. Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. Addiction. 2016;111(7):1293–8.PubMedCrossRef Kalinowski A, Humphreys K. Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. Addiction. 2016;111(7):1293–8.PubMedCrossRef
20.
go back to reference Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer - a systematic review. Dan Med J. 2012;59(6):A4444.PubMed Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer - a systematic review. Dan Med J. 2012;59(6):A4444.PubMed
21.
go back to reference Stefansson T, Moller PH, Sigurdsson F, Steingrimsson E, Eldon BJ. Familial risk of colon and rectal cancer in Iceland: evidence for different etiologic factors? Int J Cancer. 2006;119(2):304–8.PubMedCrossRef Stefansson T, Moller PH, Sigurdsson F, Steingrimsson E, Eldon BJ. Familial risk of colon and rectal cancer in Iceland: evidence for different etiologic factors? Int J Cancer. 2006;119(2):304–8.PubMedCrossRef
22.
go back to reference Zhu J, Tan Z, Hollis-Hansen K, Zhang Y, Yu C, Li Y. Epidemiological trends in colorectal cancer in China: an ecological study. Dig Dis Sci. 2017;62(1):235–43.PubMedCrossRef Zhu J, Tan Z, Hollis-Hansen K, Zhang Y, Yu C, Li Y. Epidemiological trends in colorectal cancer in China: an ecological study. Dig Dis Sci. 2017;62(1):235–43.PubMedCrossRef
23.
go back to reference Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987–2015.PubMedPubMedCentralCrossRef Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987–2015.PubMedPubMedCentralCrossRef
24.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.PubMedCrossRef DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.PubMedCrossRef
25.
go back to reference Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120(3):257–63.PubMedCrossRef Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120(3):257–63.PubMedCrossRef
26.
go back to reference Imperiale TF, Monahan PO, Stump TE, Ransohoff DF. Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults. Gut. 2021;70(6):1155–61.PubMedCrossRef Imperiale TF, Monahan PO, Stump TE, Ransohoff DF. Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults. Gut. 2021;70(6):1155–61.PubMedCrossRef
27.
go back to reference Hong SN, Son HJ, Choi SK, Chang DK, Kim YH, Jung SH, et al. A prediction model for advanced colorectal neoplasia in an asymptomatic screening population. PLoS One. 2017;12(8):e0181040.PubMedPubMedCentralCrossRef Hong SN, Son HJ, Choi SK, Chang DK, Kim YH, Jung SH, et al. A prediction model for advanced colorectal neoplasia in an asymptomatic screening population. PLoS One. 2017;12(8):e0181040.PubMedPubMedCentralCrossRef
28.
go back to reference Guo L, Chen H, Wang G, Lyu Z, Feng X, Wei L, et al. Development of a risk score for colorectal cancer in Chinese males: a prospective cohort study. Cancer Med. 2020;9(2):816–23.PubMedCrossRef Guo L, Chen H, Wang G, Lyu Z, Feng X, Wei L, et al. Development of a risk score for colorectal cancer in Chinese males: a prospective cohort study. Cancer Med. 2020;9(2):816–23.PubMedCrossRef
29.
go back to reference Chen G, Mao B, Pan Q, Liu Q, Xu X, Ning Y. Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province. Chin J Cancer Res. 2014;26(1):4–11.PubMedPubMedCentral Chen G, Mao B, Pan Q, Liu Q, Xu X, Ning Y. Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province. Chin J Cancer Res. 2014;26(1):4–11.PubMedPubMedCentral
30.
go back to reference Aleksandrova K, Reichmann R, Kaaks R, Jenab M, Bueno-de-Mesquita HB, Dahm CC, et al. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score. BMC Med. 2021;19(1):1.PubMedPubMedCentralCrossRef Aleksandrova K, Reichmann R, Kaaks R, Jenab M, Bueno-de-Mesquita HB, Dahm CC, et al. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score. BMC Med. 2021;19(1):1.PubMedPubMedCentralCrossRef
31.
go back to reference Betes M, Munoz-Navas MA, Duque JM, Angos R, Macias E, Subtil JC, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98(12):2648–54.PubMed Betes M, Munoz-Navas MA, Duque JM, Angos R, Macias E, Subtil JC, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98(12):2648–54.PubMed
32.
go back to reference Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, et al. External validation of risk prediction models for incident colorectal cancer using UK Biobank. Br J Cancer. 2018;118(5):750–9.PubMedPubMedCentralCrossRef Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, et al. External validation of risk prediction models for incident colorectal cancer using UK Biobank. Br J Cancer. 2018;118(5):750–9.PubMedPubMedCentralCrossRef
33.
go back to reference Kim SE, Paik HY, Yoon H, Lee JE, Kim N, Sung MK. Sex- and gender-specific disparities in colorectal cancer risk. World J Gastroenterol. 2015;21(17):5167–75.PubMedPubMedCentralCrossRef Kim SE, Paik HY, Yoon H, Lee JE, Kim N, Sung MK. Sex- and gender-specific disparities in colorectal cancer risk. World J Gastroenterol. 2015;21(17):5167–75.PubMedPubMedCentralCrossRef
34.
go back to reference Lin KJ, Cheung WY, Lai JY, Giovannucci EL. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer. 2012;130(2):419–30.PubMedCrossRef Lin KJ, Cheung WY, Lai JY, Giovannucci EL. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer. 2012;130(2):419–30.PubMedCrossRef
35.
go back to reference Bae JM, Kim JH, Cho NY, Kim TY, Kang GH. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer. 2013;109(4):1004–12.PubMedPubMedCentralCrossRef Bae JM, Kim JH, Cho NY, Kim TY, Kang GH. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer. 2013;109(4):1004–12.PubMedPubMedCentralCrossRef
36.
go back to reference Huang KE, Xu L, I NN, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas. 2010;65(3):276–83.PubMedCrossRef Huang KE, Xu L, I NN, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas. 2010;65(3):276–83.PubMedCrossRef
37.
go back to reference Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102(10):680–91.PubMedCrossRef Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102(10):680–91.PubMedCrossRef
38.
go back to reference Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1450–63.PubMedCrossRef Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1450–63.PubMedCrossRef
39.
go back to reference Harrison H, Thompson RE, Lin Z, Rossi SH, Stewart GD, Griffin SJ, et al. Risk Prediction Models for Kidney Cancer: A Systematic Review. Eur Urol Focus. 2021;7(6):1380-1390. Harrison H, Thompson RE, Lin Z, Rossi SH, Stewart GD, Griffin SJ, et al. Risk Prediction Models for Kidney Cancer: A Systematic Review. Eur Urol Focus. 2021;7(6):1380-1390.
40.
go back to reference Allen N, Sudlow C, Downey P, Peakman T, Danesh J, Elliott P, Gallacher J, Green J, Matthews P, Pell J, Sprosen T, Collins R. UK Biobank: Current status and what it means for epidemiology. Health Policy Technol. 2012;1(3):123–6.CrossRef Allen N, Sudlow C, Downey P, Peakman T, Danesh J, Elliott P, Gallacher J, Green J, Matthews P, Pell J, Sprosen T, Collins R. UK Biobank: Current status and what it means for epidemiology. Health Policy Technol. 2012;1(3):123–6.CrossRef
41.
go back to reference Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med. 2015;163(5):339–46.PubMedPubMedCentralCrossRef Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med. 2015;163(5):339–46.PubMedPubMedCentralCrossRef
42.
go back to reference McGeoch L, Saunders CL, Griffin SJ, Emery JD, Walter FM, Thompson DJ, et al. Risk prediction models for colorectal cancer incorporating common genetic variants: a systematic review. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1580–93.PubMedPubMedCentralCrossRef McGeoch L, Saunders CL, Griffin SJ, Emery JD, Walter FM, Thompson DJ, et al. Risk prediction models for colorectal cancer incorporating common genetic variants: a systematic review. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1580–93.PubMedPubMedCentralCrossRef
43.
go back to reference Saunders CL, Kilian B, Thompson DJ, McGeoch LJ, Griffin SJ, Antoniou AC, et al. External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using UK Biobank. Cancer Prev Res (Phila). 2020;13(6):509–20.CrossRef Saunders CL, Kilian B, Thompson DJ, McGeoch LJ, Griffin SJ, Antoniou AC, et al. External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using UK Biobank. Cancer Prev Res (Phila). 2020;13(6):509–20.CrossRef
44.
45.
go back to reference Chen H, Li N, Shi J, Ren J, Liu C, Zhang Y, et al. Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial. BMJ Open. 2019;9(4):e025935.PubMedPubMedCentralCrossRef Chen H, Li N, Shi J, Ren J, Liu C, Zhang Y, et al. Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial. BMJ Open. 2019;9(4):e025935.PubMedPubMedCentralCrossRef
46.
go back to reference Chen H, Lu M, Liu C, Zou S, Du L, Liao X, et al. Comparative evaluation of participation and diagnostic yield of colonoscopy vs fecal immunochemical test vs risk-adapted screening in colorectal cancer screening: interim analysis of a multicenter randomized controlled trial (TARGET-C). Am J Gastroenterol. 2020;115(8):1264–74.PubMedCrossRef Chen H, Lu M, Liu C, Zou S, Du L, Liao X, et al. Comparative evaluation of participation and diagnostic yield of colonoscopy vs fecal immunochemical test vs risk-adapted screening in colorectal cancer screening: interim analysis of a multicenter randomized controlled trial (TARGET-C). Am J Gastroenterol. 2020;115(8):1264–74.PubMedCrossRef
Metadata
Title
External validation of models for predicting risk of colorectal cancer using the China Kadoorie Biobank
Authors
Roxanna E. Abhari
Blake Thomson
Ling Yang
Iona Millwood
Yu Guo
Xiaoming Yang
Jun Lv
Daniel Avery
Pei Pei
Peng Wen
Canqing Yu
Yiping Chen
Junshi Chen
Liming Li
Zhengming Chen
Christiana Kartsonaki
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-022-02488-w

Other articles of this Issue 1/2022

BMC Medicine 1/2022 Go to the issue